New evidence in the management of CMV infection: impact on prophylaxis and treatment. (PubMed, Rev Esp Quimioter) - Oct 29, 2025 - "The role of novel agents such as letermovir and maribavir is highlighted. These findings support personalized strategies that balance efficacy, toxicity, and resistance in managing CMV infection."
Journal • Review • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Solid Organ Transplantation • Transplantation
|